鶹ýɫƬ

News

Study: Testimonials can open acceptance to differing opinions

Mike Krings
By Mike Krings
Oct. 14, 2023

It’s hard to change people’s minds, especially on a topic they feel strongly about. But a new study from the University of Kansas shows that testimonials about a person’s lived experience can open people to acceptance of attitudes different than their own on controversial topics. That could go a long way in helping communicators reach people on important topics regarding health, life, death and other difficult to discuss issues, researchers say.

A study surveyed nearly 1,500 people on their attitudes about several controversial issues, including if they were in favor of or opposed to physician-assisted suicide. When they then read a testimonial that gave a moving account of a person’s lived experience with the issue, they were more likely to be receptive to an attitude different than their own than those who read an informative article on the same topic.

“At their core, testimonials are essentially the story of someone’s lived experience. They can be evocative or emotional. But much of the research on narratives tends to focus on much bigger productions like movies, television or books rather than how testimonials or simpler forms of stories affect people, but not on how effective they can be in everyday life,” said Judy Watts, assistant professor of journalism and mass communications at KU and lead author of the study. “Physician-assisted suicide is a very polarizing issue that can elicit complex and mixed emotions. It hit all the areas we are interested in with researching communication processes and persuasion about issues that involve life and death.”

Participants in the study were randomly assigned either a testimonial or an informative article on the topic, so some received a testimonial or article that aligned with their previous beliefs, while others did not. They then answered another set of questions about how they felt on the topic afterward. Those who read testimonials on physician-assisted suicide, whether pro or con, were the most willing to accept or consider the value of opposing views.

“Regardless of baseline attitudes, they were a little more willing to accept the persuasive argument of the testimonial, even when it differed from their own,” Watts said.

Written with co-authors Michael Slater and Emily Moyer-Gusé of Ohio State University, the study was published in the journal

The findings can help communicators craft messages that are more likely to effectively reach their target audiences, especially if it involves a controversial or sensitive topic, the researchers wrote. During the COVID-19 pandemic, testimonials were used frequently to encourage people to take the vaccine, encourage their family members to do so and to take other protective measures. Those came at a time when there was much public debate about the vaccines, masking, business and school closures and other measures that elicited strong reactions.

While movies and larger productions have long known the influence of an engaging story on audiences, many communicators do not have the budgets or other resources to craft such an elaborate message. The findings also show that testimonials can be effective in eudaimonic situations, or when people are striving to do what is meaningful, even if it is difficult to achieve. In a media-saturated environment it is difficult to produce messages that reach people, and better understanding the effectiveness of certain types of communications can help, especially those with limited budgets and means, reach their target audiences, researchers said.

Watts, who conducts research on the said she hopes to continue studying the effects of testimonials on other topics, including those that might not be as controversial but are still emotionally fraught, such as end-of-life conversations about whether to resuscitate and end-of-life wishes.

“A thoughtful and emotional testimonial can help reach people. We’ll continue to study what happens when people encounter testimonials on topics that might not be easy to discuss but are nonetheless important for health-related decision making and behaviors,” Watts said.

This article was first published by the University of Kansas.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Mike Krings
Mike Krings

Mike Krings is a public affairs officer in the KU News Service.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Elucidating how chemotherapy induces neurotoxicity
Award

Elucidating how chemotherapy induces neurotoxicity

Dec. 2, 2024

Andre Nussenzweig will receive the Bert and Natalie Vallee Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Where do we search for the fundamental stuff of life?
Essay

Where do we search for the fundamental stuff of life?

Dec. 1, 2024

Recent books by Thomas Cech and Sara Imari Walker offer two perspectives on where to look for the basic properties that define living things.

UCLA researchers engineer experimental drug for preventing heart failure after heart attacks
News

UCLA researchers engineer experimental drug for preventing heart failure after heart attacks

Nov. 30, 2024

This new single-dose therapy blocks a protein that increases inflammation and shows promise in enhancing muscle repair in preclinical models.

The decision to eat may come down to these three neurons
News

The decision to eat may come down to these three neurons

Nov. 28, 2024

The circuit that connects a hunger-signaling hormone to the jaw to stimulate chewing movements is surprisingly simple, Rockefeller University researchers have found.

Curiosity turned a dietitian into a lipid scientist
Award

Curiosity turned a dietitian into a lipid scientist

Nov. 27, 2024

Judy Storch will receive the Avanti Award in Lipids at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

From receptor research to cancer drug development: The impact of RTKs
Award

From receptor research to cancer drug development: The impact of RTKs

Nov. 26, 2024

Joseph Schlessinger will receive the ASBMB Herbert Tabor Research Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.